New York City, NY24 days ago
Ensure access pull-through for all Ipsen Rare Disease therapies by proactively educating HCPs, office staff, and specialty pharmacy partners on coverage requirements, payer policies, prior authorization pathways, and patient out-of-pocket costs across commercial, Medicare Part D, and Medicaid channels. The FAD provides education and reimbursement support to Healthcare Providers (HCPs), healthcare institutions, prior authorization staff, and financial counselors, and addresses patient-specific access challenges including affordability, prior authorization, coverage gaps, and reimbursement.